Trial Library Emerges Out Of Stealth With $5 Million In Seed Funding, Led By Lux Capital
08/18/22, 10:34 AM
Location
san franciscoIndustry
medical
biotechnology
health care
Round Type
seed
Trial Library, Inc., an oncology clinical trials company, today announced it has come out of stealth mode and received its first funding to address the need for equity in patient recruitment to oncology clinical trials. The $5 million seed round was led by Deena Shakir, Partner at Lux Capital, with participation from Julian Eison, Managing Partner at NEXT VENTŪRES, Unseen Capital, as well as other notable angel investors. This investment supports the growing need for more inclusivity in oncology clinical trials, and will expand the usage of the Trial Library platform among community oncologists who are patients' trusted sources for advice on clinical trials.
Company Info
Location
san francisco, california, united states
Additional Info
Trial Library is an oncology clinical trials company helping patients, providers, and pharmaceutical sponsors of clinical trials. With an unprecedented level of investment in cancer research that is poised to produce a vast new array of therapeutic options, Trial Library seeks to improve access for all patients right when therapies are available. For more information, visit us at TrialLibrary.com and follow us on LinkedIn and Twitter.
1 "MAKING THE CASE FOR ONCOLOGY CLINICAL RESEARCH" American Society of Clinical Oncology, May 2020. https://www.asco.org/sites/new-www.asco.org/files/content-files/research-and-progress/documents/2020-ASCO-RCF-MakingCaseOncologyResearch-AtaGlance.pdf
2 "Clinical Trial Enrollment of Racial, Ethnic, and Underrepresented Groups—Leveraging a Digital Infrastructure" JAMA Oncology, August 5, 2021. https://jamanetwork.com/journals/jamaoncology/article-abstract/2782739
Contact: Hala Borno hala.borno@triallibrary.com
SOURCE Trial Library, Inc